Pharmacological reactivity of resistance vessels in a rat PCOS model - Vascular effects of parallel vitamin D3 treatment

Gynecological Endocrinology

Volumn 28, Issue 12, 2012, Pages 961-964

  Sara, Levente ^a   Nadasy, Gyorgy L ^a   Antal, Peter ^a   Monori Kiss, Anna ^a   Szekeres, Maria ^a   Masszi, Gabriella ^b   Monos, Emil ^a   Varbiro, Szabolcs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

Dihydrotestosterone; NO; PCOS; Relaxation; Vitamin D

Indexed keywords

ACETYLCHOLINE; ANDROSTANOLONE; COLECALCIFEROL; NITRIC OXIDE; NORADRENALIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTERIOLE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERANDROGENISM; LOW DRUG DOSE; MUSCLE CONTRACTILITY; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; TREATMENT DURATION; VASOCONSTRICTION; VASODILATATION; VITAMIN SUPPLEMENTATION;

ANIMALS; ARTERIOLES; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHOLECALCIFEROL; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; ENDOTHELIUM, VASCULAR; FEMALE; INJECTIONS, SUBCUTANEOUS; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; THIGH; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 84869987224     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.683079     Document Type: Article

References (18)

1. Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med 2008;26:39-44.
2. Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007;148:3781-3791.
3. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R, et al. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med 2011;8:103-115.
4. Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M, Rees DA. Metformin reduces arterial stifness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 2010;95:722-730.
5. Naka KK, Kalantaridou SN, Kravariti M, Bechlioulis A, Kazakos N, Calis KA, Makrigiannakis A, et al. Efect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril 2011;95:203-209.
6. Tys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian J P. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999;64:430-435.
7. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2010;299:H1226-H1234.
8. Przybylski R, McCune S, Hollis B, Simpson RU. Vitamin D defciency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis 2010;20:641-646.
9. Sara L, Antal P, Masszi G, Buday A, Horvath EM, Hamar P, Monos E, et al. Arteriolar insulin resistance in a rat model of polycystic ovary syndrome. Fertil Steril 2012;97:462-468.
10. Várbíró S, Nádasy GL, Monos E, Vajó Z, Acs N, Miklós Z, Tökés AM, Székács B. Efect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats. J Hypertens 2000;18:1587-1595.
11. Varbiro S, Matrai M, Szekeres M, Nadasy GL, Szaky E, Mericli M, Banhidy F, et al. Intramural coronary artery constrictor reactivity to thromboxane is higher in male than in female rats. Gynecol Endocrinol 2006;22:44-47.
12. Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:5088-5095.
13. Soyman Z, Noyan V, Tulmac M, Yucel A, Sagsoz N, Bayrak T, Bayrak A, Cakir E. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery fow-mediated dilatation in women with polycystic ovary syndrome. Fertil Steril 2011;95:1067-1072.
14. Arikan S, Akay H, Bahceci M, Tuzcu A, Gokalp D. Te evaluation of endothelial function with fow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function. Fertil Steril 2009;91:450-455.
15. Cussons AJ, Watts GF, Stuckey BG. Dissociation of endothelial function and arterial stifness in nonobese women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2009;71:808-814.
16. Meyer C, McGrath BP, Teede HJ. Efects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007;30:471-478.
17. Somjen D, Posner GH, Stern N. Less calcemic Vitamin D analogs enhance creatine kinase specifc activity and modulate responsiveness to gonadal steroids in the vasculature. J Steroid Biochem Mol Biol 2006;101:232-238.
18. Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles D W, Morley R, Parkington HC. Vitamin D insufciency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol (Lond) 2011;589:4777-4786.